Evidence map›Paper›PMID 25338635›Full record

ArticleBMC complementary and alternative medicine2014

Anti-cancer activity of Ginger (Zingiber officinale) leaf through the expression of activating transcription factor 3 in human colorectal cancer cells.

Gwang Hun Park, Jae Ho Park, Hun Min Song, Hyun Ji Eo, Mi Kyoung Kim, Jin Wook Lee, Man Hyo Lee, Kiu-Hyung Cho, Jeong Rak Lee, Hyeon Je Cho and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Optimization of Enzyme-Assisted Extraction from Ginger (Preventive nutrition and food science · 2024
    Article
  7. Antitumor and Phytochemical Properties ofMolecules (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Protective effect of ginger (RSC advances · 2019
    Article
  18. Article
  19. Oncology letters · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Gwang Hun Park
Jae Ho Park
Hun Min Song
Hyun Ji Eo
Mi Kyoung Kim
Jin Wook Lee
Man Hyo Lee
Kiu-Hyung Cho
Jeong Rak Lee
Hyeon Je Cho
Jin Boo JeongDepartment of Bioresource Sciences, Andong National University, Andong 760749, South Korea. jjb0403@anu.ac.kr.
Andong National University · KRGyeongbuk Marine Bio-Industry Research Institute · KRJungwon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGinger leaf (GL) has long been used as a vegetable, tea and herbal medicine. However, its pharmacological properties are still poorly understood. Thus, we performed in vitro studies to evaluate anti-cancer properties of ginger leaf and then elucidate the potential mechanisms involved.

methodsCell viability was measured by MTT assay. ATF3 expression level was evaluated by Western blot or RT-PCR and ATF3 transcriptional activity was determined using a dual-luciferase assay kit after the transfection of ATF3 promoter constructs. In addition, ATF3-dependent apoptosis was evaluated by Western blot after ATF3 knockdown using ATF3 siRNA.

resultsExposure of GL to human colorectal cancer cells (HCT116, SW480 and LoVo cells) reduced the cell viability and induced apoptosis in a dose-dependent manner. In addition, GL reduced cell viability in MCF-7, MDA-MB-231 and HepG-2 cells. ATF3 knockdown attenuated GL-mediated apoptosis. GL increased activating transcription factor 3 (ATF3) expressions in both protein and mRNA level and activated ATF3 promoter activity, indicating transcriptional activation of ATF3 gene by GL. In addition, our data showed that GL-responsible sites might be between -318 and -85 region of the ATF3 promoter. We also observed that ERK1/2 inhibition by PD98059 attenuated GL-mediated ATF3 expression but not p38 inhibition by SB203580, indicating ERK1/2 pathway implicated in GL-induced ATF3 activation.

conclusionsThese findings suggest that the reduction of cell viability and apoptosis by GL may be a result of ATF3 promoter activation and subsequent increase of ATF3 expression through ERK1/2 activation in human colorectal cancer cells.

Indexed as

Activating Transcription Factor 3Antineoplastic AgentsApoptosisCell Line, TumorColorectal NeoplasmsHumansMAP Kinase Signaling SystemPlant ExtractsPlant LeavesPromoter Regions, GeneticSignal TransductionTranscriptional ActivationZingiber officinaleActivating Transcription Factor 3Antineoplastic AgentsPlant Extracts

Identifiers

PMID25338635
PMCPMC4210498
OpenAlexW2007728964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.